ConductScience.org, home

Paper2201248

Antimicrobial susceptibility of Haemophilus ducreyi.

Dangor Y and 3 others. Antimicrob Agents Chemother, 1990. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Antimicrobial susceptibility of Haemophilus ducreyi. Papers, record 2201248. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2201248

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antimicrobial susceptibility of Haemophilus ducreyi.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1990
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.71
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dangor YY
2Ballard RCR C
3Miller SDS D
4Koornhof HJH J

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Haemophilus ducreyiMajor topic
Microbial Sensitivity Tests

References60

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13512872The treatment of chancroid.JAMA1986https://conductscience.org/library/papers/3512872PubMed
23484804AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa.N Engl J Med1986https://conductscience.org/library/papers/3484804PubMed
33010843Plasmid-mediated aminoglycoside phosphotransferases in Haemophilus ducreyi.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/3010843PubMed
43015016Susceptibility of Haemophilus ducreyi to ampicillin and sulbactam in vitro.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3015016PubMed
53733082Three day oral course of Augmentin to treat chancroid.Genitourin Med1986https://conductscience.org/library/papers/3733082PubMed
62942458Susceptibility of Haemophilus ducreyi to spectinomycin in vitro.Genitourin Med1986https://conductscience.org/library/papers/2942458PubMed
73489439Clinical evaluation of rosoxacin for the treatment of chancroid.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3489439PubMed
82946262In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/2946262PubMed
93566241Single-dose ceftriaxone for chancroid.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3566241PubMed
103494720Comparison of antimicrobial susceptibility patterns of fifty-seven strains of Haemophilus ducreyi isolated in Amsterdam from 1978 to 1985.J Antimicrob Chemother1987https://conductscience.org/library/papers/3494720PubMed
113555055Treatment of chancroid with ciprofloxacin. A prospective, randomized clinical trial.Am J Med1987https://conductscience.org/library/papers/3555055PubMed
122956702A comparison of single-dose spectinomycin with five days of trimethoprim-sulfamethoxazole for the treatment of chancroid.Sex Transm Dis1987https://conductscience.org/library/papers/2956702PubMed
132959199In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/2959199PubMed
143679217Aetiology of genital ulceration in the Gambia.Genitourin Med1987https://conductscience.org/library/papers/3679217PubMed
153293526Evaluation of 500- and 1,000-mg doses of ciprofloxacin for the treatment of chancroid.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3293526PubMed
163044978Treating chancroid with enoxacin.Genitourin Med1988https://conductscience.org/library/papers/3044978PubMed
173264133Antimicrobial susceptibilities of southern African isolates of Haemophilus ducreyi.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3264133PubMed
183264554Antibiotic susceptibilities and plasmid profiles of Haemophilus ducreyi isolates from southern Africa.J Antimicrob Chemother1988https://conductscience.org/library/papers/3264554PubMed
193074466Clinical and microbiological efficacy of a single dose of norfloxacin in the treatment of chancroid.Scand J Infect Dis Suppl1988https://conductscience.org/library/papers/3074466PubMed
202760495Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes.J Infect Dis1989https://conductscience.org/library/papers/2760495PubMed

See all 60 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
39287406Infections caused by Haemophilus ducreyi: one organism, two stories.Clin Microbiol Rev2024https://conductscience.org/library/papers/39287406PubMed
28027326Haemophilus ducreyi Cutaneous Ulcer Strains Diverged from Both Class I and Class II Genital Ulcer Strains: Implications for Epidemiological Studies.PLoS Negl Trop Dis2016https://conductscience.org/library/papers/28027326PubMed
26392647Antibiotic resistance in prevalent bacterial and protozoan sexually transmitted infections.Indian J Sex Transm Dis AIDS2015https://conductscience.org/library/papers/26392647PubMed
26147869Haemophilus ducreyi Cutaneous Ulcer Strains Are Nearly Identical to Class I Genital Ulcer Strains.PLoS Negl Trop Dis2015https://conductscience.org/library/papers/26147869PubMed
21825292The MUT056399 inhibitor of FabI is a new antistaphylococcal compound.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21825292PubMed
9756778Haemophilus ducreyi is susceptible to protegrin.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9756778PubMed
8239617Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8239617PubMed
7979300Emergence of Haemophilus ducreyi resistance to trimethoprim-sulfamethoxazole in Rwanda.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7979300PubMed
7553570Chancroid and Haemophilus ducreyi: an update.Clin Microbiol Rev1995https://conductscience.org/library/papers/7553570PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2201248

GET https://conductscience.org/api/papers/v1/2201248/references?page=2